Takasaki, S. et al. 2021. Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma. Journal of Pharmacy & Pharmaceutical Sciences. 24, (Mar. 2021), 127–136. DOI:https://doi.org/10.18433/jpps31816.